Livmarli 9.5 mg/mL oral solution Images
Generic Name: maralixibat
This medication has been identified as Livmarli 9.5 mg/mL oral solution. It is supplied by Mirum Pharmaceuticals Inc.
Livmarli is used in the treatment of Cholestatic Pruritus in Alagille Syndrome; Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis and belongs to the drug class miscellaneous GI agents. Livmarli 9.5 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Livmarli
- Generic Name
- maralixibat
- Strength
- 9.5 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Miscellaneous GI agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mirum Pharmaceuticals Inc.
- National Drug Code (NDC)
- 79378-0110
See also:
Bylvay
Bylvay (odevixibat) is an oral capsule that may be used to treat itching (pruritus) caused by ...
Actidose-Aqua
Actidose-Aqua is used for gas, gastrointestinal decontamination
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Activated Charcoal
Activated Charcoal is used for gas, gastrointestinal decontamination
Alka-Seltzer Anti-Gas
Alka-Seltzer Anti-Gas is used for endoscopy or radiology premedication, functional gastric ...
Anti-Gas Ultra Strength
Anti-Gas Ultra Strength is used for endoscopy or radiology premedication, functional gastric ...
Baby Gasz
Baby Gasz is used for endoscopy or radiology premedication, functional gastric disorder, gas ...
Carafate
Carafate is an anti-ulcer medication used to treat active duodenal ulcers. Learn about side ...
More about Livmarli (maralixibat)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous GI agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.